NuCana plc - American Depositary Share (NCNA): Price and Financial Metrics
NCNA Price/Volume Stats
| Current price | $1.28 | 52-week high | $19.41 |
| Prev. close | $1.33 | 52-week low | $1.26 |
| Day low | $1.28 | Volume | 69,600 |
| Day high | $1.34 | Avg. volume | 447,966 |
| 50-day MA | $2.14 | Dividend yield | N/A |
| 200-day MA | $4.27 | Market Cap | 3.38M |
NCNA Stock Price Chart Interactive Chart >
NuCana plc - American Depositary Share (NCNA) Company Bio
NuCana plc develops anti-cancer medicines for ovarian, biliary, pancreatic, colorectal, haematology, oncology, and breast cancers. NuCana produces oncology medicines using a proprietary technology platform for cancer patients. The company was incorporated in 1997 and is based in Edinburgh, the United Kingdom.
NCNA Price Returns
| 1-mo | -30.81% |
| 3-mo | -81.95% |
| 6-mo | -63.64% |
| 1-year | -88.77% |
| 3-year | -98.08% |
| 5-year | -99.28% |
| YTD | -82.69% |
| 2023 | -55.18% |
| 2022 | -72.27% |
| 2021 | -46.99% |
| 2020 | -26.39% |
| 2019 | -57.93% |
Loading social stream, please wait...